Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Non-Current Deffered Revenue (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Non-Current Deffered Revenue for 3 consecutive years, with $322000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Deffered Revenue fell 10.06% to $322000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $322000.0, a 10.06% decrease, with the full-year FY2024 number at $300000.0, down 13.54% from a year prior.
  • Non-Current Deffered Revenue was $322000.0 for Q3 2025 at SANUWAVE Health, up from $301000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $358000.0 in Q3 2024 to a low of $215000.0 in Q2 2023.
  • A 3-year average of $304818.2 and a median of $311000.0 in 2025 define the central range for Non-Current Deffered Revenue.
  • Peak YoY movement for Non-Current Deffered Revenue: soared 62.79% in 2024, then dropped 14.0% in 2025.
  • SANUWAVE Health's Non-Current Deffered Revenue stood at $347000.0 in 2023, then decreased by 13.54% to $300000.0 in 2024, then rose by 7.33% to $322000.0 in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Non-Current Deffered Revenue are $322000.0 (Q3 2025), $301000.0 (Q2 2025), and $311000.0 (Q1 2025).